NovaBridge Biosciences (NBP)
NASDAQ
NBP price, last 12 months
Key stats
- Previous close
- $0.9031
- Open
- $0.9033
- Day range
- $0.8500 – $0.9033
- 52-week range
- $0.7507 – $5.19
- Volume
- 213.7K
- Avg volume (20 days)
- 562.4K
- Market cap
- $98.3M
Performance
Technicals and fundamentals
About NovaBridge Biosciences
NovaBridge Biosciences operates as a biotechnology platform, combining business development and clinical research to identify and advance pharmaceutical assets. Its inventive immuno-oncology pipeline consists of three clinical stage programs, givastomig; uliledlimab; and ragistomig. Its core product, givastomig, is a potential in-class CLDN18.2 bispecific antibody for the treatment of gastric cancer and other CLDN18.2-positive gastrointestinal malignancies.
- Listed on
- NASDAQ
- Market cap
- $98.3M